Inviragen, PharmaJet gets needle-free dengue vaccine develpoment grant
The award is expected to fund preclinical studies, regulatory filings, manufacturing and clinical testing of Inviragen’s tetravalent dengue vaccine, DENVax delivered with PharmaJet’s convenient needle-free injection device. Inviragen
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.